STEVEN M. PAUL - 17 Jun 2025 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
RAPP
Transactions as of
17 Jun 2025
Transactions value $
$0
Form type
4
Filing time
18 Jun 2025, 16:15:08 UTC
Previous filing
06 Jun 2024
Next filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PAUL STEVEN M Director RAPPORT THERAPEUTICS, INC., 99 HIGH STREET, SUITE 2100, BOSTON /s/ Troy Ignelzi, Attorney-in-Fact 18 Jun 2025 0001237564

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPP Stock Option (Right to Buy) Award $0 +21.9K $0.00 21.9K 17 Jun 2025 Common Stock 21.9K $10.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest upon the earlier of (i) June 17, 2026 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.